Summary:
Click image to enlargeA Randomized, Double-Blind, Placebo Controlled, Parallel Arm, Multicenter, Phase 2 Study To Evaluate The Efficacy And Safety Of Lorundrostat In Subjects With Uncontrolled Hypertension On A Standardized Medication Regimen
Criteria:- Must be 18 years or older
- Must be clinically diagnosed with Hypertension
Qualified Participants May Receive:
Compensation up to $2,000
No Cost Study Medication
No Cost Lab Examination
Treatment possibility for Hypertension